Legal & General Group
THRN

Legal & General Group’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Legal & General Group’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,325
Closed -$13.5K – 3419
2023
Q3 		$13.5K Sell
1,325
-99
-7% -$754 ﹤0.01% 3186
2023
Q2 		$6.69K Hold
1,424
– – ﹤0.01% 3359
2023
Q1 		$6.42K Hold
1,424
– – ﹤0.01% 3268
2022
Q4 		$5.17K Hold
1,424
– – ﹤0.01% 3345
2022
Q3 		$7K Sell
1,424
-190
-12% -$955 ﹤0.01% 3383
2022
Q2 		$8K Buy
1,614
+914
+131% +$5.56K ﹤0.01% 3408
2022
Q1 		$4K Buy
700
+176
+34% +$947 ﹤0.01% 3527
2021
Q4 		$3K Buy
+524
New +$4.09K ﹤0.01% 3567

Legal & General Group's THRN Position: Q4 2023 in Review

Legal & General Group sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 1,325 shares — an estimated $13.5K sold.

Legal & General Group first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $13.5K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Legal & General Group reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Legal & General Group sold 1,325 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $13.5K.
  • Legal & General Group first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Legal & General Group's Thorne Healthtech, Inc. Common Stock position peaked at $13.5K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Legal & General Group's 13F filing for Q4 2023, filed 15 Feb 2024.